ACTRN12621000484842招募中未知
Targeted Screening for Congenital Cytomegalovirus-related Hearing loss in infants up to 14 days old in Western Australia
Dr Jafri Kuthubutheen0 个研究点目标入组 140 人开始时间: 2021年4月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 14 Days（—）
- 性别
- All
入选标准
- •During the 2 year study
- •1. all infants born in Western Australia undergoing newborn hearing screening which results in a 'refer' (fail) result in one or both ears
- •2. Are age less than day 11 for rural/remote infants and day 14 for infants in metropolitan area on the day the 'refer' result is received by the study team
- •3. Has a legally acceptable representative able to provide informed consent on behalf of the infant
排除标准
- •1. Newborn hearing screen ‘refer’ result but infant aged over 11 days of age (rural/remote participants) and 14 days of age (metropolitan participant)
- •2. Medically unwell – although not specifically excluded from the study some Infants may be too unwell to reasonably take part. In consultation with the treating team, the research team would consider the appropriateness of approaching the guardians.
- •3. Lack of a legally acceptable representative able to provide informed consent on behalf of the infant.
研究者
相似试验
招募中
不适用
A target screening for congenital cytomegalovirus infection in pregnant women and newbornsCongenital cytomegalovirus infectionJPRN-UMIN000045977Teine Keijinkai Hospital2,000
已完成
不适用
Screening for cytomegalovirus in pregnant womecytomegalovirus infectionJPRN-UMIN000012607Kobe University2,000
招募中
不适用
Tests of cytomegalovirus fetomaternal infectioCytomegalovirus fetomaternal infectionJPRN-UMIN000020055Mie University30
已完成
不适用
Screening for Congenital Cytomegalovirus Infection in NewbornsCytomegalovirus InfectionsNCT02683096Southern Illinois University75
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 18.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-DEBiotest AG16,000